Skip to main content

Table 1 Expression of IMP3 in patients with lung adenocarcinoma

From: IMP3 can predict aggressive behaviour of lung adenocarcinoma

Variable   N IMP3 (N = 90) P
    Negative N (%) Positive N (%)  
Gradus 1 18 8 (29.6) 10 (15) 0.287
  2 23 7 (25.9) 16 (25)  
  3 49 12 (44) 37 (58)  
Subtype solid 52 9 (33) 43 (68) 0.002
  others 38 18 (66) 20 (31)  
Napsin A negative/light 60 12 (46) 48 (77) 0.004
  strong positive 28 14 (53) 14 (22)  
TTF-1 negative 31 9 (33.3) 22 (39.2) 0.599
  positive 52 18 (66.6) 34 (60.7)  
Pleural effusion no 29 6 (42.8) 3 (76.6) 0.063
  yes 15 8 (16.6) 7 (23.3)  
T staging 2 10 4 (33.3) 6 (21.4) 0.458
  3 10 2 (16.6) 8 (28.5)  
  4 20 6 (50) 14 (50)  
N staging 1 20 9 (64) 11 (52.3) 0.612
  2 14 5 (35) 9 (42.8)  
  3 1 0 1 (4)  
M staging 0 31 10 (37) 22 (34.9) 0.033
  1a 14 8 (29.6) 6 (9.5)  
  1b 45 9 (33.3) 36 (55.5)  
  1. χ2 test.